Testing effectiveness (Phase 2)Looking for participantsNCT04172532
What this trial is testing
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer AJCC v8
National Cancer Institute (NCI) 92